Celia Morgan



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial

As we all know alcohol addiction is one of the worst addictions in society costing billions per year. A 2010 […]


Awakn announces first-ever study investigating ketamine in gambling addiction treatment

When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about gambling addiction. […]


Awakn Life Sciences’ Anthony Tennyson on using researched backed psychedelic drugs and therapies to treat Alcohol Use Disorder

In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO: AWKN) about […]


Anthony Tennyson on Awakn Life Sciences bringing innovation in addiction treatment to the market

In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO: AWKN) about […]